Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 trial of Brozopentyl Sodium injection in acute ischemic stroke
ChiCTR2500107880Phase 2Recruiting
- Sponsor
- First Affiliated Hospital of Jinan University
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Brozopentyl Sodium in ischemic stroke (4 arms), sponsored by First Affiliated Hospital of Jinan University. Primary endpoint: Change in NIHSS score at Day 14. Started Aug 2025; status: recruiting.
02
Drugs
Brozopentyl Sodium
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR2500107880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500107880.